UBS Lux Equity Fund Biotech USD vs DNB Aktiv 80 A

UBS Lux Equity Fund Biotech USD vs DNB Aktiv 80 A

1. UBS Lux Equity Fund Biotech USD

  • Security

    UBS Lux Equity Fund Biotech USD P-acc

  • Fee

    2.25%

  • ISIN

    LU0069152568

  • Holdings

    10

2. DNB Aktiv 80 A

  • Security

    DNB Aktiv 80 A

  • Fee

    1.04%

  • ISIN

    NO0010337793

  • Holdings

    3

Fund Holdings

We have information about 14 holdings in UBS Lux Equity Fund Biotech USD, where the largest holding is Regeneron Pharmaceuticals (10.04), followed by Vertex (9.9) and Moderna (9.21). In comparison with DNB Aktiv 80 A, we have 3 holdings where Proethos Fond is the largest holding (19.72), followed by Alfred Berg Optimal D (5.4) and Nordnet One Offensiv (2.9).

All Holdings

Here we compare the holdings in UBS Lux Equity Fund Biotech USD and DNB Aktiv 80 A.

UBS Lux Equity Fund Biotech USD DNB Aktiv 80 A
1. Regeneron Pharmaceuticals Inc
10.04 %
1. Proethos Fond
Sweden
19.72 %
2. Vertex Pharmaceuticals Inc
9.9 %
2. Alfred Berg Optimal D
5.4 %
3. Moderna Inc
9.21 %
3. Nordnet One Offensiv NOK
Sweden
2.9 %
4. Alnylam Pharmaceuticals Inc
6.54 %
-
5. AbbVie Inc
USA
5.52 %
-
6. Gilead Sciences Inc
USA
4.66 %
-
7. Amgen Inc
4.32 %
-
8. BioNTech SE
4.13 %
-
9. Karuna Therapeutics Inc
3.75 %
-
10. Royalty Pharma Plc
3.28 %
-

The list of fund holdings was last updated on April 17, 2025.